Day: October 11, 2023

High-speed, high-quality printing and superior durability contribute to improved efficiency in logistics and inventory management label applicationsROHM’s New Thermal Printheads, Optimized for Barcode Label PrintersHigh-speed, highly reliable thermal printheads deliver print quality and durability that exceeds conventional limitsROHM’s Thermal Printheads: Product DetailsThe TE2004-QP1W00A (203dpi) and TE3004-TP1W00A (300dpi) significantly improve on the substrate material, structure, and wiring pattern over existing productsSanta Clara, CA and Kyoto, Japan, Oct. 11, 2023 (GLOBE NEWSWIRE) — ROHM Semiconductor today announced the TE2004-QP1W00A / TE3004-TP1W00A high-speed, highly reliable thermal printheads, optimized for barcode label printers applied in logistics and inventory management. In recent...

Green Hydrogen to Power Largest Advanced-Stage Sustainable Aviation Fuel Project LATHAM, N.Y., Oct. 11, 2023 (GLOBE NEWSWIRE) — Arcadia eFuels has selected Plug Power Inc. (NASDAQ: PLUG), a comprehensive provider of turnkey hydrogen solutions for the global green hydrogen economy, to provide a 280 MW (megawatt) proton exchange membrane (PEM) electrolyzer system to Arcadia’s Vordingborg plant for the production of sustainable aviation fuel (SAF). Arcadia eFuels CEO Amy Hebert and Plug CEO Andy Marsh held a ceremony commemorating the deal at Plug’s annual Symposium.  Harnessing Denmark’s plentiful wind power, Arcadia eFuels Vordingborg site will utilize Plug’s electrolyzer technology to produce approximately 120 tons per day (TPD) of green hydrogen. The green hydrogen will then be combined with biogenic CO2 to produce syngas. Further...

TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, provides an update on the development of a next generation lyophilized formulation of Bucillamine. Under an agreement with the University of Waterloo, formulation development is ongoing and aims to be completed by the end of December 2023. Discussions with contract development manufacturing organizations with expertise in the clinical manufacturing of lyophilized products are ongoing. The Company expects to have its novel lyophilized formulation of Bucillamine ready for clinical evaluation in 2024. The Company intends to explore the novel Bucillamine formulation as a...

SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that eight abstracts highlighting new data from its chronic hepatitis B (CHB) and chronic hepatitis delta (CHD) clinical programs have been accepted for presentation at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting®, taking place in Boston, MA, from November 10-14, 2023. These include seven poster presentations, one of which is a late-breaking poster, and one late-breaking oral presentation. “Results from our ongoing studies underscore the tremendous progress we are making toward addressing the needs of the millions of people living with chronic hepatitis B and chronic hepatitis delta,” said Phil Pang, M.D., Ph.D., Vir’s Executive Vice President, Chief Medical Officer and Interim Head of Research....

Martin Beck Appointed CEO, Replacing Samuel Meckey Announces the Elimination of 20 Corporate Roles DELRAY BEACH, Fla., Oct. 11, 2023 (GLOBE NEWSWIRE) — UpHealth, Inc. (“UpHealth,” the “Company”) (NYSE: UPH), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced the October 5, 2023 appointment by the Board of Directors of the Company of Martin Beck to serve as the Company’s next Chief Executive Officer, replacing Samuel Meckey, effective October 6, 2023, and Mr. Beck being named as a member of the Board of Directors effective October 9, 2023. Mr. Beck has been UpHealth’s Chief Financial Officer since February 2020. Jay Jennings, currently the Company’s Chief Accounting Officer, will assume the role of Chief Financial Officer....

TORONTO and HAIFA, Israel, Oct. 11, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone”), a biopharmaceutical company developing biologically-guided exosome therapy (“ExoTherapy”) for patients with acute spinal cord injuries (“SCI”), is thrilled to announce that the Company has been awarded a 1M New Israeli Shekels (NIS) (~CAD$350K) grant by the Israel Innovation Authority (“IIA”) as part of the Israel-Canada bilateral Eureka program. The grant is for a collaboration with Canada-based Inteligex Inc. (“Inteligex”) to develop an innovative hybrid therapy tailored for the complex chronic spinal cord injury market. This endeavor combines Inteligex’s established expertise in stem cell treatments with NurExone’s ExoTherapy drug delivery platform. Currently, NurExone is in the process...

Ohmyhome LtdSimply Sakal Pte. Ltd.Strategic transaction creates an industry leading one-stop-shop property “Super App” Enhances Ohmyhome’s comprehensive technology and service offering to end-customers around buying, selling, renovating, and managing properties Transaction is expected to be accretive to Ohmyhome’s revenue growth and earnings in 2024, the first full year after its close, and lead to a positive EBITDA in 2025 upon the realization of the synergiesSingapore, Oct. 11, 2023 (GLOBE NEWSWIRE) — Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”, “the Company”), a one-stop-shop property technology platform providing end-to-end property solutions and services to buy, sell, rent, and renovate homes, announces the acquisition of Simply Sakal Pte. Ltd (“Simply”), a leading tech-enabled property management company in Singapore,...

MALVERN, Pa., Oct. 11, 2023 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, will release its financial results for the third quarter of fiscal 2023 before the opening of the market on Tuesday, November 7, 2023. Ziv Shoshani, chief executive officer, and Bill Clancy, chief financial officer, will host a conference call that day (Tuesday, November 7, 2023) at 9:00 a.m. U.S. Eastern Time. To access the conference call, interested parties should call 1-833-470-1428 or internationally +1-404-975-4839 and use passcode 636531, or may access the live webcast by visiting the “Events” page of the investor relations section of the VPG website at http://ir.vpgsensors.com. A webcast replay will be available for a limited time approximately one hour after the completion...